CEFTRIAXONE 1 GM VIAL

What it is

CEFTRIAXONE 1 GM VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “ceftriaxone” and “ceftriaxone sodium”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as injection, powder, for solution and its route as intramuscular; intravenous.

FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Hospira, Inc and Sandoz Inc.

FDA’s Established Pharmacologic Class for it is Cephalosporin Antibacterial.

The NADAC file of 2026-10-14 prices it under 10 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.17 – $1.44 for 1 unit (EA), depending on the NDC ($1.17324 to $1.44341 per EA), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

The 8 labelers

Other strengths, forms and brands

3 other products in the NADAC file share an FDA nonproprietary name with CEFTRIAXONE 1 GM VIAL.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-02-18, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 10 NDCs’ NADAC prices is $1.44341 per EA filed.

Of the 20 other products in FDA’s Cephalosporin Antibacterial class priced per EA, 6 have a higher middle NADAC price and 14 a lower one. The one in the middle is CEFPODOXIME 100 MG TABLET, at $1.0434 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part B’s payment limit for HCPCS J0696, for 2026-10-01 to 2026-12-31, comes to $1.56 for 1 unit (EA), or $1.56 per EA once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.078 per 250 MG.

Medicare's price is not your price.

What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
• Which NDC (the 11-digit number on the package) is this? Pharmacies pay $1.17324 to $1.44341 per EA for this product, depending on the NDC.
• If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.